Different Metabolism and Toxicity of TRANS Fatty Acids, Elaidate and Vaccenate Compared to Cis-Oleate in HepG2 Cells.

cardiovascular diseases ceramide diabetes diacylglycerol endoplasmic reticulum stress lipotoxicity non-alcoholic fatty liver disease obesity trans fatty acid

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
30 Jun 2022
Historique:
received: 20 04 2022
revised: 25 06 2022
accepted: 28 06 2022
entrez: 9 7 2022
pubmed: 10 7 2022
medline: 14 7 2022
Statut: epublish

Résumé

Trans fatty acids (TFAs) are not synthesized in the human body but are generally ingested in substantial amounts. The widespread view that TFAs, particularly those of industrial origin, are unhealthy and contribute to obesity, cardiovascular diseases and diabetes is based mostly on in vivo studies, and the underlying molecular mechanisms remain to be elucidated. Here, we used a hepatoma model of palmitate-induced lipotoxicity to compare the metabolism and effects of the representative industrial and ruminant TFAs, elaidate and vaccenate, respectively, with those of cis-oleate. Cellular FAs, triacylglycerols, diacylglycerols and ceramides were quantitated using chromatography, markers of stress and apoptosis were assessed at mRNA and protein levels, ultrastructural changes were examined by electron microscopy and viability was evaluated by MTT assay. While TFAs were just slightly more damaging than oleate when applied alone, they were remarkably less protective against palmitate toxicity in cotreatments. These differences correlated with their diverse incorporation into the accumulating diacylglycerols and ceramides. Our results provide in vitro evidence for the unfavorable metabolic features and potent stress-inducing character of TFAs in comparison with oleate. These findings strengthen the reasoning against dietary trans fat intake, and they can also help us better understand the molecular mechanisms of lipotoxicity.

Identifiants

pubmed: 35806300
pii: ijms23137298
doi: 10.3390/ijms23137298
pmc: PMC9266973
pii:
doi:

Substances chimiques

Ceramides 0
Diglycerides 0
Fatty Acids 0
Oleic Acids 0
Palmitates 0
Trans Fatty Acids 0
Oleic Acid 2UMI9U37CP
elaidic acid 4837010H8C

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Hungarian National Research, Development and Innovation Office
ID : K 125201
Organisme : Hungarian National Research, Development and Innovation Office
ID : FK 138115
Organisme : Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund
ID : TKP2021-EGA-24
Organisme : Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund
ID : TKP2021-EGA-02

Références

Sci Rep. 2018 Jan 24;8(1):1535
pubmed: 29367652
Molecules. 2021 Sep 26;26(19):
pubmed: 34641380
World J Hepatol. 2013 Oct 27;5(10):550-7
pubmed: 24179614
J Biol Chem. 2009 Feb 27;284(9):5637-44
pubmed: 19119140
Am J Clin Nutr. 2007 Jul;86(1):74-81
pubmed: 17616765
Eur Heart J. 2016 Apr 1;37(13):1079-81
pubmed: 26582177
EBioMedicine. 2018 Apr;30:261-272
pubmed: 29606629
Pediatr Obes. 2019 Sep;14(9):e12528
pubmed: 30957427
J Nutr. 2010 Jan;140(1):18-24
pubmed: 19923390
Diabetes Care. 2022 Apr 1;45(4):845-853
pubmed: 35129607
Science. 1957 Oct 11;126(3276):698-9
pubmed: 13467268
Eur J Clin Nutr. 2001 Jan;55(1):59-64
pubmed: 11303495
Am J Epidemiol. 1998 Dec 1;148(11):1085-93
pubmed: 9850131
Food Funct. 2020 Jan 29;11(1):649-661
pubmed: 31895396
Am J Clin Nutr. 1960 Jul-Aug;8:499-511
pubmed: 13714574
Front Cell Dev Biol. 2019 Oct 01;7:210
pubmed: 31632963
Scand J Clin Lab Invest. 1998 Dec;58(8):635-45
pubmed: 10088200
J Dairy Sci. 1993 Dec;76(12):3851-63
pubmed: 8132891
PLoS One. 2013 Sep 13;8(9):e74283
pubmed: 24058537
N Engl J Med. 2006 Apr 13;354(15):1601-13
pubmed: 16611951
Lipids. 2011 Jul;46(7):647-57
pubmed: 21614647
Adv Nutr. 2020 May 1;11(3):697-708
pubmed: 31782488
Life Sci. 2018 Jun 15;203:291-304
pubmed: 29709653
Diabetes Metab Syndr. 2019 Mar - Apr;13(2):1643-1647
pubmed: 31336535
Int J Mol Sci. 2020 Apr 09;21(7):
pubmed: 32283839
Am J Clin Nutr. 2001 Jun;73(6):1019-26
pubmed: 11382654
Mol Nutr Food Res. 2016 Apr;60(4):846-57
pubmed: 27061233
Biomed Res Int. 2013;2013:276174
pubmed: 24222900
Food Chem Toxicol. 2019 Feb;124:324-335
pubmed: 30572061
Nutr Metab (Lond). 2020 Jan 30;17:11
pubmed: 32021639
Curr Res Transl Med. 2017 Jan - Mar;65(1):20-30
pubmed: 28340693
Mol Med Rep. 2017 Dec;16(6):9337-9346
pubmed: 29152653
Trends Pharmacol Sci. 2021 Dec;42(12):1082-1095
pubmed: 34750017
Front Endocrinol (Lausanne). 2021 Mar 12;12:667885
pubmed: 33776946
BMJ. 2015 Aug 11;351:h3978
pubmed: 26268692
Biochem Biophys Res Commun. 2013 Nov 29;441(4):770-6
pubmed: 24189472
Proteome Sci. 2015 Dec 01;13:31
pubmed: 26628894
Am J Clin Nutr. 1998 Sep;68(3):561-7
pubmed: 9734731
Eur J Lipid Sci Technol. 2011 Oct;113(10):1281-1292
pubmed: 22164125
J Biol Chem. 2002 Jul 19;277(29):25843-6
pubmed: 12011104

Auteurs

Farkas Sarnyai (F)

Department of Molecular Biology, Semmelweis University, H-1094 Budapest, Hungary.

Éva Kereszturi (É)

Department of Molecular Biology, Semmelweis University, H-1094 Budapest, Hungary.

Kitti Szirmai (K)

Department of Molecular Biology, Semmelweis University, H-1094 Budapest, Hungary.

Judit Mátyási (J)

Department of Inorganic and Analytical Chemistry, Budapest University of Technology and Economics, H-1111 Budapest, Hungary.

Johanna Iman Al-Hag (JI)

Department of Inorganic and Analytical Chemistry, Budapest University of Technology and Economics, H-1111 Budapest, Hungary.

Tamás Csizmadia (T)

Department of Anatomy, Cell and Developmental Biology, Eötvös Loránd University, H-1053 Budapest, Hungary.

Péter Lőw (P)

Department of Anatomy, Cell and Developmental Biology, Eötvös Loránd University, H-1053 Budapest, Hungary.

Péter Szelényi (P)

Department of Molecular Biology, Semmelweis University, H-1094 Budapest, Hungary.

Viola Tamási (V)

Department of Molecular Biology, Semmelweis University, H-1094 Budapest, Hungary.

Kinga Tibori (K)

Department of Molecular Biology, Semmelweis University, H-1094 Budapest, Hungary.

Veronika Zámbó (V)

Department of Molecular Biology, Semmelweis University, H-1094 Budapest, Hungary.

Blanka Tóth (B)

Department of Inorganic and Analytical Chemistry, Budapest University of Technology and Economics, H-1111 Budapest, Hungary.

Miklós Csala (M)

Department of Molecular Biology, Semmelweis University, H-1094 Budapest, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH